Clinical Phase II Study on the first-line chemotherapy for B stage Non-squmaous cell lung cancer, comparing Pemetrexed/Carboplatin with Gemcitabine/Carboplatin.

Trial Profile

Clinical Phase II Study on the first-line chemotherapy for B stage Non-squmaous cell lung cancer, comparing Pemetrexed/Carboplatin with Gemcitabine/Carboplatin.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 May 2012

At a glance

  • Drugs Carboplatin; Gemcitabine; Pemetrexed
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Planned number of patients changed from 80 to 40 as reported by Chinese Clinical Trial Register record.
    • 02 Jan 2012 Planned number of patients changed from 40 to 80 as reported by Chinese Clinical Trial Register.
    • 02 Jan 2012 Status changed from not yet recruiting to recruiting as reported by Chinese Clinical Trial Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top